Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-22

FDA Approved: PRETOMANID — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for Pretomanid submitted by Viatris Specialty LLC, updating its labeling to reflect its use in drug-resistant tuberculos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pretomanid (pretomanid)

Snippet

SUPPL AP for PRETOMANID (PRETOMANID)